Pure Bioscience (PURE) 0.7300 $PURE PURE Resubmits Food

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pure Bioscience (PURE) 0.7300 $PURE

PURE Resubmits Food Contact Notification to FDA for SDC Antimicrobial Use in Raw Poultry Processing
Marketwired - Wed Jun 17, 7:41AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that it has resubmitted a Food Contact Notification (FCN) to the US Food and Drug Administration (FDA) for Silver Dihydrogen Citrate (SDC) as an online reprocessing (OLR) antimicrobial for raw poultry processing.

Pure Bioscience's (PURE) CEO Hank Lambert Discusses Q3 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Jun 11, 9:46PM CDT


PURE Bioscience reports FQ3 results
Seeking Alpha - at Seeking Alpha - Thu Jun 11, 3:06PM CDT


PURE Bioscience Reports 2015 Fiscal Third Quarter and Nine-Month Financial Results
Marketwired - Thu Jun 11, 3:02PM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal three and nine-month periods ended April 30, 2015.

PURE Bioscience to Present at the 2015 Impact Investor Conference on June 19th
Marketwired - Wed Jun 10, 7:36AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today the Company will present at the 2015 Impact Investor Conference hosted by The Brewer Group Companies, GWG Holdings, Inc., and Greentree Financial Group on Friday, June 19, 2015 at the Minneapolis Club in Minneapolis, MN.
GWGH: 8.85 (+0.15)

PURE Bioscience Hosts Fiscal Q3 Results Conference Call June 11, 2015 to Review Progress of SDC-Based Food Safety Solutions Strategy
Marketwired - Thu Jun 04, 7:36AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that the Company will host an investor conference call on Thursday, June 11, 2015 at 1:30pm PDT (4:30pm EDT).

PURE Bioscience Prepares to Resubmit Food Contact Notification With FDA for SDC Antimicrobial Use in Raw Poultry Processing
Marketwired - Wed Jun 03, 3:03PM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that as a result of recent discussions with the FDA, PURE intends to resubmit its Food Contact Notification (FCN) for use of its SDC antimicrobial in raw poultry processing before the end of June.

PURE Bioscience to Present at the 2015 Marcum MicroCap Conference on May 28th
Marketwired - Mon May 18, 7:41AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today the Company will present at the 2015 Marcum MicroCap Conference on Thursday, May 28, 2015 in New York City at the Grand Hyatt Hotel.

PURE Bioscience to Present at the 2nd Annual Growth Capital Expo on April 13th
Marketwired - Thu Apr 09, 3:03PM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today the Company will present at the 2nd Growth Capital Expo being held on April 12-14, 2015 at Caesars Palace in Las Vegas, NV.

PURE Bioscience's (PURE) CEO Hank Lambert on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Mar 04, 9:01PM CST


PURE Bioscience and Intercon Chemical Present PURE(R) Hard Surface Disinfectant to Cruise Lines International Association's Gastrointestinal Illness Technology Conference
Marketwired - Wed Feb 18, 7:42AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, and Intercon Chemical Company, the exclusively licensed manufacturer of SDC-based products, announced today the two companies made a "by invitation only" joint scientific presentation to the attendees of the Cruise Lines International Association's (CLIA) GI Illness Technology Conference in Geneva, Switzerland. Attendees of the technology conference were GI Illness task force representatives (including Infectious Disease Control Managers and Medical Directors) of the top 10 cruise lines, including Carnival Corporation, Royal Caribbean Cruises, Norwegian Cruise Lines and MSC Cruises. The invitation to present was a direct result of Intercon's sales and industry education efforts.
RCL: 82.41 (+3.90), CCL: 50.58 (+1.38)

PURE Bioscience Signs Agreement With All American Chemical Company to Distribute PURE(R) Hard Surface Disinfectant
Marketwired - Thu Feb 05, 7:41AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that it has signed a non-exclusive agreement with All American Chemical Company Inc. to distribute PURE(R) Hard Surface disinfectant to its network of more than 175+ food and beverage manufacturers/processors. The arrangement broadens and deepens the sales reach for PURE's powerful antimicrobial products.

PURE Bioscience Expands National Sales Rollout for PURE(R) Hard Surface Disinfectant at SUBWAY(R) Restaurants' Multi Unit Owners Conference
Marketwired - Mon Feb 02, 7:36AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that it broadened its SUBWAY(R) Restaurants* sales and marketing initiative as an invited preferred vendor presenter at the January 2015 SUBWAY(R) Winter Meeting of Multi Unit Owners in Miami, Florida.

PURE Bioscience Reports Fiscal First Quarter 2015 Financial Results
Marketwired - Thu Dec 11, 3:02PM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2014 (Fiscal Q1 2015).

PURE(R) Hard Surface Disinfectant Remediates Listeria Contamination in Shuttered Food Processing Facility
Marketwired - Wed Dec 10, 7:34AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that Dr. James L. Marsden, Ph.D., Distinguished Professor-Food Safety and Security Kansas State University, has released a White Paper (click-here) which details the successful remediation of Listeria contamination in a food processing facility. The decontamination of the plant was achieved by utilizing a cleaning and sanitizing program incorporating PURE(R) Hard Surface disinfectant.

PURE Bioscience to Host Fiscal Q1 Investor Conference Call Thursday, December 11, 2014
Marketwired - Tue Dec 02, 7:34AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that the Company will host an investor conference call on Thursday, December 11, 2014 at 1:30pm PST (4:30pm EST).

PURE Bioscience Updates Ongoing Sales Path for EPA Approved PURE(R) Hard Surface Disinfectant With SUBWAY(R) Restaurants and Others
Marketwired - Wed Nov 12, 7:36AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today provided an update on its sales path to commercialize PURE(R) Hard Surface as a superior disinfectant for food contact surfaces in restaurant chains and food processors/manufacturers.

PURE Withdraws Food Contact Notification for SDC Antimicrobial Use in Raw Poultry Processing
Marketwired - Mon Nov 10, 7:35AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that it has withdrawn the Food Contact Notification (FCN) it submitted to the U.S. Food and Drug Administration (FDA) in July 2014 for the use of SDC in raw poultry processing. PURE had submitted the FCN based on test results demonstrating that the SDC use provided a material significant reduction in Salmonella contamination in raw poultry.

Pure Bioscience withdraws antimicrobial FCN
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 7:25AM CST


Scroll down for more posts ▼

Top 10 Most Recent News Articles

IP Lawyer Chris Henry Returns to Latham: A Game Changer

Updated Category News Views 138

Welcome Home, Chris Henry! Folks, here's a headline that's making waves in the IP litigation water: Chris Henry has returned to Latham & Watkins, taking his place as a heavyweight partner in their Boston office. Now, if you're not deeply entangled in the world of high-stakes intellectual property (IP) disputes, you might shrug. But for tech companies embroiled in patent...

Continue Reading
Intel Faces Class Action Over Alleged Securities Fraud

Updated Category News Views 84

Intel's Legal Predicament: Decoding the Lawsuit Saddle up, folks, because Intel (NASDAQ: INTC) has found itself tangled in legal vines again. This ain't their first rodeo, and probably won't be their last. We're looking at a hefty class action lawsuit rallying on claims that Intel misled investors with optimistic yarns about their health. SBS Law, waving the litigation...

Continue Reading
Silvi's Expansion Push: New Terminal in Wilmington

Updated Category News Views 113

Silvi's Latest Bet on the Southeast You know, sometimes you get a gut feeling that a company is rolling out chess moves instead of checkers. That’s what Silvi Materials is up to with their new project in Wilmington. It’s not just some fancy cement terminal—it’s a calculated expansion into the heart of the Southeast construction market. The Port of Wilmington’s...

Continue Reading
Visit W&H at the Greater New York Dental Meeting

Updated Category News Views 89

Why This Event Matters for Dental Professionals Stroll through any convention center halls and you can see the future unfolding right in front of you. The upcoming Greater New York Dental Meeting is no different, especially with W&H Group setting up shop. For any dental professionals out there, this is your chance to get your hands on some real-deal tech that might just...

Continue Reading
AvidXchange Acquisition Faces Fairness Investigation

Updated Category News Views 100

Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...

Continue Reading
Portillo's Faces Legal Heat: Investor Class Action Filed

Updated Category News Views 162

What’s Eating Portillo's? Ah, once upon a misstep in the land of promising expansion, now we have Portillo's Inc. (NASDAQ: PTLO) neck-deep in legal hot water. Those golden fries and famous sandwiches somehow didn't pave the way for stockholder bliss. Why the turmoil? On an ordinary November morning, the DJS Law Group made it clear: They're rallying the troops for a...

Continue Reading
Greenberg Traurig Cheers Clients' 69th GRAMMY® Nods

Updated Category News Views 49

A Momentous Occasion for Greenberg Traurig's Entertainment Clients Oh, the glamour and glitz of the music world! There's nothing quite like the GRAMMY® Awards to stir up a blend of excitement, ego, and anxiety in the industry. This time around, the lawyers over at Greenberg Traurig are beaming with pride as their clients scoop up nominations for the 69th Annual GRAMMY®...

Continue Reading
Christian Faith: Navigating Spiritual Pitfalls Wisely

Updated Category News Views 195

Taking a Deep Look at Christian Faith If you think faith is as simple as saying a few prayers and checking church attendance off the list, well, think again. G. Joseph Johnson, in his thought-provoking tome "Roads, Ditches, Traps, and Snares," believes that faith is a journey filled with twists, turns, and yes, a few traps. This book is a sort of roadmap for Christians,...

Continue Reading
Palatin's Game-Changer: MC4R Agonist Hits the Stage

Updated Category News Views 103

Breaking New Ground in Obesity Treatment Palatin Technologies is stepping into the spotlight with some heavy ammunition in the fight against obesity. The company has just unveiled impressive preclinical data about their next-generation melanocortin-4 receptor (MC4R) agonists at the ObesityWeek® 2026 conference. This isn’t just your run-of-the-mill corporate...

Continue Reading
SKE Capitalizes on Halloween Events in London

Updated Category News Views 104

SKE's Bold Step into London's Halloween Vibe Hah! Who would've thought that vaping and Halloween could be a match made in heaven? This year, SKE threw its hat into the ring and wrestled for attention in London’s bustling Halloween music scene. Imagine an entire warehouse pulsing not just with beat-heavy electronic music, but the energy of vaping enthusiasts courtesy of...

Continue Reading

Top 5 Most Recently Viewed Articles

Why Investors Are Making Bold Moves with Dell Technologies

Updated Category News Views 178

Investors Show Confidence in Dell Technologies In recent trading sessions, significant investors have adopted a bullish approach to Dell Technologies (NYSE: DELL). Such movements usually signal investor confidence and the possibility of future price movements. Interestingly, options trading data we've analyzed indicates that this activity stemmed from large transactions,...

Continue Reading
Community Heritage Financial Strengthens Capital Position with Debt Offering

Updated Category News Views 78

Community Heritage Financial Completes Subordinated Debt Offering Community Heritage Financial, Inc. (OTC PK: CMHF), parent company of Middletown Valley Bank, has successfully executed a private placement of subordinated debt, amounting to a substantial $12.1 million. This offering of 6.75% Fixed-to-Floating Rate Subordinated Notes, due 2034, reflects the Company’s...

Continue Reading
Evolent Health Poised for Growth Amid Humana Challenges

Updated Category News Views 185

Understanding Evolent Health's Market Position Recently, analysts at Barclays have reaffirmed their positive outlook on Evolent Health (NYSE: EVH), maintaining an Overweight rating and a price target of $39.00. This confidence comes in light of discussions surrounding the impacts of Humana's recent struggles with Medicare Star ratings. The management team at Evolent,...

Continue Reading
Caracole Teams with Centric PLM for Seamless Growth

Updated Category News Views 31

Revolutionizing the Luxury Furniture Game In the world of luxury furnishings, where every curve and finish sends a message, Caracole is making a bold move to streamline its operations. They're throwing the confetti for Centric PLM, a platform that's set to oust the scattered chaos of spreadsheets and emails. And let me tell you, for any investor eyeing the luxury home...

Continue Reading
RaySearch Laboratories: Exciting Year-End Presentation Ahead

Updated Category News Views 105

Join Us for RaySearch Laboratories' Year-End Report Presentation Analysts, investors, and media representatives are cordially invited to a detailed presentation focused on RaySearch Laboratories' Year-end report for the year 2024. Details of the Presentation Set for February 21, 2025, at 10:00 AM CET, the report will be made accessible to attendees starting at 07:45 AM on...

Continue Reading